Friedrich Foerster, MD is a postdoctoral fellow at TIM and a medical resident at the First Department of Medicine at the University Medical Center Mainz, Germany.
He holds a medical degree and a law degree from the University of Heidelberg, Germany. His medical studies included one year of clinical courses at the Karolinska Institute in Stockholm, Sweden, a clinical elective at Singapore General Hospital, Singapore, and a one-year visiting research scholarship in the laboratory of Ronald A. Depinho MD at the Dana-Farber Cancer Institute/Harvard Medical School in Boston, USA. Before starting his residency in 2012, he worked as a consultant at McKinsey, an international strategy consulting firm, for one year.
F. Foerster started his biomedical research in the field of cancer genetics focusing on telomere biology, the p53-mediated transcriptome and the DNA damage response. He is now working on the tumor immunology of liver cancer/metastasis, the development of nanoparticle-based drug delivery systems and immune-related gene signatures in gastrointestinal malignancies.
1. Zhang Y, Shin SJ, Liu D, Ivanova E, Foerster F, Ying H, Zheng H, Xiao Y, Chen Z, Protopopov A, Depinho RA, Paik JH. ZNF365 promotes stability of fragile sites and telomeres. Cancer Discovery 2013; 3:798-811.
2. Sahin E, Colla S, Liesa M, Moslehi J, Müller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, Maser RS, Tonon G, Foerster F, Xiong R, Wang YA, Shukla SA, Jaskelioff M, Martin ES, Heffernan TP, Protopopov A, Ivanova E, Mahoney JE, Kost-Alimova M, Perry SR, Bronson R, Liao R, Mulligan R, Shirihai OS, Chin L, DePinho RA. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011; 470:359-65.